CAS NO: | 1425945-60-3 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | EHT 1610 is a potent inhibitor ofDYRK, withIC50sof 0.36 nM (DYRK1A), 0.59 nM (DYRK1B), respectively. EHT 1610 exhibits antileukemia effect, regulates cell cycle and induces cellapoptosis[1]-[4]. | ||||||||||||||||
IC50& Target | IC50: 0.36 nM (DYRK1A), 0.59 nM (DYRK1B)[1] | ||||||||||||||||
体外研究 (In Vitro) | EHT 1610 induces apoptosis of primary ALL cells that were resistant to cytarabine[2]. Western Blot Analysis[3]
| ||||||||||||||||
体内研究 (In Vivo) | EHT 1610 (20 mg/kg/d; i.p.; twice a day; 3 weeks) shows antileukemia activity against in leukemic aggressive model in mice[3].
| ||||||||||||||||
分子量 | 383.40 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C18H14FN5O2S | ||||||||||||||||
CAS 号 | 1425945-60-3 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | -20°C, protect from light, stored under nitrogen *该产品在溶液状态不稳定,建议您现用现配,即刻使用。 | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 5 mg/mL(13.04 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现用现配,即刻使用。 |